AU5802894A - New substituted azetidinones as anti-inflammatory and antidegenerative agents - Google Patents
New substituted azetidinones as anti-inflammatory and antidegenerative agentsInfo
- Publication number
- AU5802894A AU5802894A AU58028/94A AU5802894A AU5802894A AU 5802894 A AU5802894 A AU 5802894A AU 58028/94 A AU58028/94 A AU 58028/94A AU 5802894 A AU5802894 A AU 5802894A AU 5802894 A AU5802894 A AU 5802894A
- Authority
- AU
- Australia
- Prior art keywords
- inflammatory
- new substituted
- substituted azetidinones
- antidegenerative agents
- antidegenerative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/992,414 US5348953A (en) | 1991-06-25 | 1992-12-17 | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| PCT/US1993/012229 WO1994013636A1 (en) | 1992-12-17 | 1993-12-15 | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US992414 | 2001-11-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5802894A true AU5802894A (en) | 1994-07-04 |
Family
ID=25538317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU58028/94A Abandoned AU5802894A (en) | 1992-12-17 | 1993-12-15 | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5802894A (en) |
| WO (1) | WO1994013636A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0869943A1 (en) * | 1995-12-08 | 1998-10-14 | Smithkline Beecham Plc | Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| WO1997041098A1 (en) * | 1996-04-26 | 1997-11-06 | Smithkline Beecham Plc | Azetidinone derivatives for the treatment of atherosclerosis |
| US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| KR101238525B1 (en) | 2004-12-31 | 2013-02-28 | 레디 유에스 테라퓨틱스 인코포레이티드 | Novel benzylamine derivatives as cetp inhibitors |
| EP2590951B1 (en) | 2010-07-09 | 2015-01-07 | Pfizer Limited | Benzenesulfonamides useful as sodium channel inhibitors |
| CA2801032A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| WO2012007869A2 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
| JP2013532186A (en) | 2010-07-12 | 2013-08-15 | ファイザー・リミテッド | Compound |
| EP2593428B1 (en) | 2010-07-12 | 2014-11-19 | Pfizer Limited | N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
| ES2532357T3 (en) | 2010-07-12 | 2015-03-26 | Pfizer Limited | Sulfonamide derivatives as Nav1.7 inhibitors for pain treatment |
| CN116942661B (en) * | 2023-08-01 | 2024-10-15 | 深圳市中医院 | Application of L635 in construction of mouse spasmolytic polypeptide expression metaplasia model |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| IL89835A0 (en) * | 1988-04-11 | 1989-12-15 | Merck & Co Inc | Substituted azetidinones,their preparation and pharmaceutical compositions containing them |
-
1993
- 1993-12-15 WO PCT/US1993/012229 patent/WO1994013636A1/en not_active Ceased
- 1993-12-15 AU AU58028/94A patent/AU5802894A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994013636A1 (en) | 1994-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8583391A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU1858392A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU4165993A (en) | Aminediol compounds and derivatives and halohydrin intermediates | |
| AU4211193A (en) | New carbohydrate-based anti-inflammatory agents | |
| AU4166393A (en) | Auto-reclosers | |
| AU3561193A (en) | TNF-muteins | |
| AU3991693A (en) | Pyrazinoindoles | |
| AU4669293A (en) | Cholesterol-lowering agents | |
| AU3042892A (en) | Rockbolt | |
| AU4829793A (en) | Quinazoline derivatives | |
| AU5587594A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU4177593A (en) | Benzophenonehydrazones | |
| AU3551993A (en) | Tetraazacyclododecane derivative and its use | |
| AU685767B2 (en) | Substituted benzazepinones | |
| FI951992A7 (en) | Novel substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU7080094A (en) | Substituted azetidinone amide derivatives as anti-inflammatory and antidegenerative agents | |
| AU5802894A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU4156393A (en) | Heterocyclyltriazolinones | |
| AU4164793A (en) | Heterocyclyltriazolinones | |
| AU3461693A (en) | Saddle-cloth | |
| AU5371694A (en) | Use of the tarchonanthus camphoratus | |
| AU4632493A (en) | Weathershed | |
| EP0505095A3 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| EP0505097A3 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| AU3185693A (en) | Pyrrolylbenzodiazepinones |